Glenmark Unit Gets US OK To Sell Copy Of Contraceptive Drug
03 Avril 2012 - 8:15AM
Dow Jones News
Glenmark Pharmaceuticals Ltd. (532296.BY) said Tuesday its
generic drugs unit has received U.S. regulatory approval to
manufacture and sell a generic version of Teva Women's Health
Inc.'s Mircette contraceptive tablets.
The company plans to start shipping the generic version, called
Viorele, immediately, it said in a statement.
Total sales of desogestrel and ethinyl estradiol and ethinyl
estradiol combination, which is used to make Mircette, were about
$98 million in 2011, the company said, citing IMS Health market
research data.
-By Rumman Ahmed, Dow Jones Newswires; 91-9845104173;
rumman.ahmed@dowjones.com